GlassScriptPhysician profile
Tarkan Sidal
NPI 1407036502
$3,761.57
in general payments reported to CMS, 2019-2025
9 companies · $721 in 2025
The $721 reported for 2025 was more than what 78% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $2,005 · 2021: $55.82 · 2022: $222 · 2023: $107 · 2024: $505 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,344.00 | 2019-2025 | |
| Kls-Martin L.P. | $929.81 | 2023-2025 | |
| Geistlich Pharma, North America, INC. | $171.47 | 2024-2025 | Biomaterials, Geistlich Bio-Gide |
| Henry Schein, INC. | $86.06 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Pacira Pharmaceuticals Incorporated | $83.55 | 2023-2025 | Exparel |
| Nobel Biocare USA | $60.80 | 2022 | |
| Misonix INC | $39.64 | 2019 | |
| Dentsply Sirona INC | $31.40 | 2021 | |
| Philips North America LLC | $14.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarkan Sidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.